IHC of the harvested tumour after 4 generations revealed similar characteristics to the original patient tumour, i.e. positive for CD3, CD30 and negative for CD79a (Fig. 2b) This indicates that the xenograft can propagate and retain the characteristics of the original tumour. This evidence concerns the gene TNFRSF8 and neoplasm.